If you love your morning cup of coffee but aren’t sure if it’s helping or hurting your Crohn’s symptoms, here’s what to know.

A new study from Karolinska Institutet in Sweden suggests that people with dementia who also develop inflammatory bowel ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

At Healthcare Network, we’ve long understood that a healthy community is a strong community. That’s why we remain committed to bridging health care gaps and expanding services to meet the evolving ...

Today, frequent discussion occurs surrounding the issue of non-medical exemptions for vaccination requirements for children ...

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.

Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared ...

Proponents of reining in the largely unregulated intoxicating hemp industry in Texas shared new polling data on Wednesday ...

Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed ...

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...

Gut support cells communicate with surprising precision – like brain neurons – using tiny extensions to send instructions to ...